These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21547161)

  • 1. Integrin targeted delivery of gene therapeutics.
    Juliano RL; Ming X; Nakagawa O; Xu R; Yoo H
    Theranostics; 2011 Mar; 1():211-9. PubMed ID: 21547161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of a splice-switching oligonucleotide by cationic polyplexes of RGD-oligonucleotide conjugate.
    Ming X; Feng L
    Mol Pharm; 2012 May; 9(5):1502-10. PubMed ID: 22497548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides.
    Juliano RL; Carver K; Cao C; Ming X
    J Drug Target; 2013 Jan; 21(1):27-43. PubMed ID: 23163768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.
    Juliano RL; Ming X; Carver K; Laing B
    Nucleic Acid Ther; 2014 Apr; 24(2):101-13. PubMed ID: 24383421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Manipulation of the Endosome Trafficking Machinery: Implications for Oligonucleotide Delivery.
    Juliano RL
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34063104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan-based delivery of therapeutic oligonucleotides for treatment of human diseases.
    Ossipov DA
    Expert Opin Drug Deliv; 2019 Jun; 16(6):621-637. PubMed ID: 31072142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemistry and biology of oligonucleotide conjugates.
    Juliano RL; Ming X; Nakagawa O
    Acc Chem Res; 2012 Jul; 45(7):1067-76. PubMed ID: 22353142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides.
    Kang H; DeLong R; Fisher MH; Juliano RL
    Pharm Res; 2005 Dec; 22(12):2099-106. PubMed ID: 16184444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.
    Ming X
    Expert Opin Drug Deliv; 2011 Apr; 8(4):435-49. PubMed ID: 21381985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don't.
    Juliano RL
    Nucleic Acid Ther; 2018 Jun; 28(3):166-177. PubMed ID: 29708838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent preclinical and clinical advances in oligonucleotide conjugates.
    Craig K; Abrams M; Amiji M
    Expert Opin Drug Deliv; 2018 Jun; 15(6):629-640. PubMed ID: 29727206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGD Conjugated Dendritic Polylysine for Cellular Delivery of Antisense Oligonucleotide.
    Le TD; Nakagawa O; Fisher M; Juliano RL; Yoo H
    J Nanosci Nanotechnol; 2017 Apr; 17(4):2353-357. PubMed ID: 29641161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides.
    Juliano R; Alam MR; Dixit V; Kang H
    Nucleic Acids Res; 2008 Jul; 36(12):4158-71. PubMed ID: 18558618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotides.
    Nakagawa O; Ming X; Carver K; Juliano R
    Bioconjug Chem; 2014 Jan; 25(1):165-70. PubMed ID: 24354269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The delivery of therapeutic oligonucleotides.
    Juliano RL
    Nucleic Acids Res; 2016 Aug; 44(14):6518-48. PubMed ID: 27084936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent conjugation of oligonucleotides with cell-targeting ligands.
    Alam MR; Ming X; Nakagawa O; Jin J; Juliano RL
    Bioorg Med Chem; 2013 Oct; 21(20):6217-23. PubMed ID: 23777829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides.
    Juliano RL; Wang L; Tavares F; Brown EG; James L; Ariyarathna Y; Ming X; Mao C; Suto M
    Nucleic Acids Res; 2018 Feb; 46(4):1601-1613. PubMed ID: 29361039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endosome Escape Strategies for Improving the Efficacy of Oligonucleotide Delivery Systems.
    Wan Y; Moyle PM; Toth I
    Curr Med Chem; 2015; 22(29):3326-46. PubMed ID: 26303176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes.
    Ming X; Sato K; Juliano RL
    J Control Release; 2011 Jul; 153(1):83-92. PubMed ID: 21571016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escaping the endosome: assessing cellular trafficking mechanisms of non-viral vehicles.
    Xu E; Saltzman WM; Piotrowski-Daspit AS
    J Control Release; 2021 Jul; 335():465-480. PubMed ID: 34077782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.